Evidence map›Paper›PMID 30356675›Full record

ArticleFrontiers in immunology2018

Comparative Analysis of B-Cell Receptor Repertoires Induced by Live Yellow Fever Vaccine in Young and Middle-Age Donors.

Alexey N Davydov, Anna S Obraztsova, Mikhail Y Lebedin, Maria A Turchaninova, Dmitriy B Staroverov, Ekaterina M Merzlyak, George V Sharonov, Olga Kladova, Mikhail Shugay, Olga V Britanova and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Alexey N DavydovAdaptive Immunity Group, Central European Institute of Technology, Brno, Czechia.
Anna S ObraztsovaFaculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, Russia.
Mikhail Y LebedinGenomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
Maria A TurchaninovaGenomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
Dmitriy B StaroverovGenomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
Ekaterina M MerzlyakGenomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
George V SharonovGenomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
Olga KladovaDepartment of Molecular Technologies, Pirogov Russian National Research Medical University, Moscow, Russia.
Mikhail ShugayCenter of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia.
Olga V BritanovaGenomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
Dmitriy M ChudakovAdaptive Immunity Group, Central European Institute of Technology, Brno, Czechia.
Institute of Bioorganic Chemistry · RUPirogov Russian National Research Medical University · RUPrivolzhsky Research Medical University · RUSkolkovo Institute of Science and Technology · RUCentral European Institute of Technology · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Age-related changes can significantly alter the state of adaptive immune system and often lead to attenuated response to novel pathogens and vaccination. In present study we employed 5'RACE UMI-based full length and nearly error-free immunoglobulin profiling to compare plasma cell antibody repertoires in young (19-26 years) and middle-age (45-58 years) individuals vaccinated with a live yellow fever vaccine, modeling a newly encountered pathogen. Our analysis has revealed age-related differences in the responding antibody repertoire ranging from distinct IGH CDR3 repertoire properties to differences in somatic hypermutation intensity and efficiency and antibody lineage tree structure. Overall, our findings suggest that younger individuals respond with a more diverse antibody repertoire and employ a more efficient somatic hypermutation process than elder individuals in response to a newly encountered pathogen.

Indexed as

Immunity, ActiveAdultAnimalsAntibodies, ViralB-LymphocytesFemaleHumansImmunoglobulin Constant RegionsImmunoglobulin Heavy ChainsMaleMiddle AgedReceptors, Antigen, B-CellSomatic Hypermutation, ImmunoglobulinVaccinationYellow FeverYellow Fever VaccineAntibodies, ViralImmunoglobulin Constant RegionsImmunoglobulin Heavy ChainsReceptors, Antigen, B-CellYellow Fever Vaccineageimmunoglobulin repertoireplasma cellvaccinationyellow fever

Identifiers

PMID30356675
PMCPMC6189279
OpenAlexW2897811546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.